Logos Biosystems is excited to announce participation in the upcoming CAR-TCR Summit to be held September 23 – 26, 2025 in Boston, MA (USA) at the Marriott Copley – Booth #57.

The event, organized by Hanson Wade, is dedicated to providing a platform for all areas of cell therapy research from discovery to clinical development, to early- and late-stage manufacturing, and analytical development.

Key highlights for the summit include:

New Clinical Data
Full Cell Therapy Landscape Coverage
Biotech & Biopharma Partnering Day
Comprehensive Coverage of Indications

Logos Biosystems will feature the LUNA-FX7™ automated cell counter which provides the flexibility and versatility required for complicated cell production and monitoring used in cell therapy-related research processes.

With built-in quality control features including an optional bioprocessing mode and CountWire™ (for 21 CFR, Part 11 compliance), the LUNA-FX7™ has a higher throughput and broad cell detection range making it ideal for diverse cell counting applications. Its’ small footprint makes it the perfect addition to the benchtop (in or out of the cleanroom).

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas, delivering insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

For more information or for details on how to register for the CAR-TCR Summit, please click here to be redirected to the event webpage.